-- HealthDay Staff
WEDNESDAY, March 9 (HealthDay News) -- The U.S. Food and Drug
Administration on Wednesday gave lupus patients their first new
treatment option in more than 50 years when it approved Benlysta as
a way to ease the painful symptoms of this debilitating autoimmune
Injected directly into a vein, Benlysta is the first drug
designed to target a protein that may reduce the number of abnormal
B cells believed to be at the root of lupus, the FDA said in a news
release. The last lupus drugs approved by the agency were Plaquenil
(hydroxychloroquine) and corticosteroids; both were given the
agency's blessing in 1955. Back in 1948, aspirin was approved to
treat the disease.
Lupus strikes women far more often than men, and symptoms
typically first appear between the ages of 15 and 44. The joints,
skin, kidneys, lungs, heart and brain can all be affected, and when
symptoms flare up they include swelling in the joints or joint
pain, light sensitivity, fever, chest pain, hair loss and fatigue,
the FDA said.
According to the agency, there are between 300,000 and 1.5
million lupus sufferers in the United States. Black women are three
times more likely than white women to get the disorder.
"Benlysta, when used with existing therapies, may be an important new treatment approach for health-care professionals and patients looking to help manage symptoms associated with this disease," said Dr. Curtis Rosebraugh, director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research.
The approval was widely expected after an FDA advisory panel
voted 13-2 in November to recommend approval of the drug, the
Los Angeles Times reported, and Benlysta is expected to
become a top seller for its maker, Human Genome Sciences Inc., of
Benlysta's arrival has been much heralded because it comes on
the heels of decades of disappointing efforts to craft new
treatments for lupus, Sandra Raymond, president of Lupus Foundation
of America, told the
"It's an historic day. It really does open a door," Raymond told the newspaper. "Not that Benlysta is a miracle drug. It's not. I think the lupus community is sanguine about that. But they know that there are other companies coming behind" Human Genome.
For more on lupus, go to the
U.S. National Institutes of Health.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.